Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2007
02/28/2007EP1343561B1 Serine protease inhibitors
02/28/2007EP1265606B9 Cell adhesion inhibitors
02/28/2007EP1240154B1 Serine protease inhibitors
02/28/2007CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
02/28/2007CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor
02/28/2007CN1922172A Substituted heterocyclic compounds and uses thereof
02/28/2007CN1922171A Pyrimidine derivative
02/28/2007CN1922170A Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors
02/28/2007CN1922160A Compounds
02/28/2007CN1922159A Benzamide derivatives and their use as glucokinase activating agents
02/28/2007CN1922151A Substituted azole derivatives, compositions, and methods of use
02/28/2007CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
02/28/2007CN1922141A Novel heterocyclic compound
02/28/2007CN1922139A Bicyclic amide derivatives
02/28/2007CN1301981C Medicinal composition containing 1,3-thiazine derivative
02/28/2007CN1301980C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
02/28/2007CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation
02/27/2007US7183416 Polymorph of a pharmaceutical
02/27/2007US7183413 Aminoquinoline compounds
02/27/2007US7183304 Heterocyclic compounds and methods of use
02/27/2007US7183303 Gamma-secretase inhibitors
02/27/2007US7183302 Iminothiazolidinones as inhibitors of HCV replication
02/27/2007US7183301 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one
02/27/2007US7183299 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient
02/27/2007US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes
02/27/2007US7183294 Indole derivatives useful for the treatment of diseases
02/27/2007US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
02/27/2007US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine
02/27/2007US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
02/27/2007US7183278 (Halo)alkoxy-3-(alkoxy or alkanoyl)-N-alkylene picolinamide; reacting a picolinic acid, ester or acyl halide with a primary amine; agricultural fungicides; rice blast, cucumber anthracnose, powdery mildew of cucumber and wheat leaf rust
02/27/2007US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy
02/27/2007US7183275 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
02/27/2007US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
02/27/2007US7183270 Cyclic derivatives as modulators of chemokine receptor activity
02/23/2007WO2007021308A1 Metabotropic glutamate-receptor-potentiating isoindolones
02/22/2007WO2007022258A1 Novel high affinity thiophene-based and furan-based kinase ligands
02/22/2007WO2007022257A2 Monocyclic and bicyclic compounds and methods of use
02/22/2007WO2007021982A2 Modulators of cystic fibrosis transmembrane conductance regulator
02/22/2007WO2007020936A1 Bicyclo heterocyclic compound having antifungal action
02/22/2007WO2007020460A1 Chemical process
02/22/2007WO2007020437A1 Chemical process for the preparation of benzoxazole derivatives used as pesticides
02/22/2007WO2007020411A1 Amide derivatives
02/22/2007WO2007020213A2 Thiazolyl piperidine derivatives useful as h3 receptor modulators
02/22/2007WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists
02/22/2007WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders
02/22/2007WO2007019933A1 1-acyldihydropyrazol derivatives
02/22/2007WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
02/22/2007WO2006122777A3 Use of 2,5-disubstituted thiazol-4-one derivatives in drugs
02/22/2007WO2006098834A3 Crystalline forms of ziprasidone mesylate
02/22/2007WO2006091703A3 Multimediator 5-ht6 receptor antagonists, and uses related thereto
02/22/2007US20070043223 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
02/22/2007US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties
02/22/2007US20070043094 Pioglitazone hydrochloride
02/22/2007US20070043092 Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders
02/22/2007US20070043087 Compounds exhibiting thrombopoietin receptor agonism
02/22/2007US20070043083 Thiazolyl piperidine derivatives
02/22/2007US20070043080 Substituted anilinic piperidines as MCH selective antagonists
02/22/2007US20070043065 Amide derivatives
02/22/2007US20070043051 Methods and compositions of novel triazine compounds
02/22/2007US20070043046 Biaromatic ligand activators of PPARGAMMA receptors
02/22/2007US20070043045 Novel high affinity thiophene-based and furan-based kinase ligands
02/22/2007US20070043038 Indolone-acetamide derivatives, processes for preparing them and their uses
02/22/2007US20070043037 Pyrimidine derivatives as orexin receptor antagonists
02/22/2007US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use
02/22/2007US20070043016 Method of treating fibrotic diseases or other indications with imidazolium agents
02/22/2007US20070043013 1,3 Disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
02/22/2007US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties
02/22/2007US20070042968 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease
02/22/2007DE102005038537A1 1-Acyldihydropyrazolderivate 1 Acyldihydropyrazolderivate
02/22/2007CA2619790A1 Novel high affinity thiophene-based and furan-based kinase ligands
02/22/2007CA2619706A1 Novel high affinity quinoline-based kinase ligands
02/22/2007CA2619517A1 Pyrazine kinase inhibitors
02/22/2007CA2619436A1 Chemical process for the preparation of benzoxazole derivatives used as pesticides
02/22/2007CA2619407A1 Bicyclic bisamide derivatives and use thereof as insecticides
02/22/2007CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders
02/22/2007CA2619039A1 1-acyldihydropyrazole derivatives
02/22/2007CA2618736A1 Chemical process
02/22/2007CA2618568A1 Thiazolyl piperidine derivatives useful as h3 receptor modulators
02/22/2007CA2618451A1 Amide derivatives
02/22/2007CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists
02/22/2007CA2618057A1 Modulators of cystic fibrosis transmembrane conductance regulator
02/21/2007EP1754706A1 SELECTIVE INHIBITORS AGAINST Cdk4 AND Cdk6 HAVING AMINOTHIAZOLE SKELETON
02/21/2007EP1754703A2 N-Heterocyclic derivatives as nos inhibitors
02/21/2007EP1753775A1 Process for preparing acyclic hcv protease inhibitors
02/21/2007EP1753761A2 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
02/21/2007EP1753760A1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
02/21/2007EP1753759A2 Novel co-precipitate of amorphous rosiglitazone
02/21/2007EP1753758A1 Mercaptoimidazoles as ccr2 receptor antagonists
02/21/2007EP1753750A1 Thiophene heteroaryl amines
02/21/2007EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
02/21/2007EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2007EP1753735A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
02/21/2007EP1753734A1 Nitric oxide donors and uses thereof
02/21/2007EP1753719A1 Substituted pyrrolidine-2-ones
02/21/2007EP1753718A1 3-amino-2-phenylpyrrolidine derivatives
02/21/2007EP1753423A2 Benzoureas having anti-diabetic activity
02/21/2007EP1581517B1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
02/21/2007EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
02/21/2007EP1511727B1 Aromatic sulfones and their medical use
02/21/2007EP1501508B1 Inhibitors of histone deacetylase